Enteral Clonidine for the Management of Rigors in Pediatric Oncology

Rigors are a distressing symptom commonly experienced by oncology patients and may occur secondary to infection, medications, or the disease process itself. Historically, meperidine has been used in the symptomatic management of patients experiencing rigors, but utilization and availability of this medication have declined due to safety concerns. We report the case of a 14-year-old male with acute myeloid leukemia who experienced recurrent severe rigors associated with fever throughout his illness. Enteral clonidine was initiated at a dose of 100 µg every six hours as needed for rigor management and was titrated as high as 100 µg every six hours scheduled during prolonged fever periods. The patient experienced rapid improvement in the severity of rigors following the initiation of clonidine after a single dose. These fevers had been present throughout the duration of his illness and could not always be correlated with specific infections or treatment elements. This case supports the use of enteral clonidine as a possible therapy for patients experiencing painful or distressing rigors.

Authors

Institutions

Publication Details

Journal
Journal of Palliative Medicine
Published
2026-11-12
DOI
https://doi.org/10.1177/10966218261506699
Primary Topic
Pain Management and Opioid Use
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Enteral Clonidine for the Management of Rigors in Pediatric Oncology

Stephanie Veldhuijzen van Zanten, Alexis Fong-Leboeuf
Journal of Palliative Medicine
Pain Management and Opioid Use
article

Enteral Clonidine for the Management of Rigors in Pediatric Oncology

Stephanie Veldhuijzen van Zanten, Alexis Fong-Leboeuf
article en

Abstract

Rigors are a distressing symptom commonly experienced by oncology patients and may occur secondary to infection, medications, or the disease process itself. Historically, meperidine has been used in the symptomatic management of patients experiencing rigors, but utilization and availability of this medication have declined due to safety concerns. We report the case of a 14-year-old male with acute myeloid leukemia who experienced recurrent severe rigors associated with fever throughout his illness. Enteral clonidine was initiated at a dose of 100 µg every six hours as needed for rigor management and was titrated as high as 100 µg every six hours scheduled during prolonged fever periods. The patient experienced rapid improvement in the severity of rigors following the initiation of clonidine after a single dose. These fevers had been present throughout the duration of his illness and could not always be correlated with specific infections or treatment elements. This case supports the use of enteral clonidine as a possible therapy for patients experiencing painful or distressing rigors.

Journal of Palliative Medicine
University of Ottawa (CA), Children's Hospital of Eastern Ontario (CA)
Good health and well-being
Pain Management and Opioid Use
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon